Summary: A case is presented in which gynaecomastia was the sole initial presenting symptom of a feminizing adrenocortical carcinoma. This rare pathological lesion is discussed.
increase in pressure probably was of recent origin but despite normal cardiac dimensions left ventricular function was grossly impaired with extreme hypokinaesia of the left ventricular wall. The E/A ratio was below one in both of them, suggesting reduced left ventricular compliance.
A remarkable finding in our cases was the isolated increase in plasma noradrenaline in the absence of a phaeochromocytoma. Although we cannot entirely exclude the possibility that this was secondary to the pulmonary oedema (especially not in patient 2), we think such a mechanism to be less likely because one would have expected a comparable rise in adrenaline and activation of renin. 4 The question arises, therefore, whether acute oversecretion of noradrenaline was the primary event that has induced contraction of the coronary arteries with subsequent ischaemia and hypokinaesia ofthe heart (stunning). In other words, left ventricular dysfunction during acute episodes of hypertension may be due to a direct effect of catecholamines on the heart rather than to pressure overload as is also observed in patients with phaeochromocytoma.5 '6 In conclusion, the The patient was submitted for investigation (see Table I ) and at operation (through a right 9th rib thoraco-abdominal incision), a 750 g adrenal tumour was found. It was adherent to the under surface of the liver, and tumour thrombosis extended through the adrenal vein into the inferior vena cava. The lesion was excised, along with a cuff of inferior vena cava and the patient made an uneventful recovery. Histology confirmed an adrenocortical carcinoma, necrotic in parts, with marked pleomorphism and numerous mitotic figures. Postoperatively his biochemistry returned to normal (although he required a short course of bromocriptine to reduce his serum prolactin to normal). Despite this, his gynaecomastia did not regress and he underwent excision 6 months after his adrenalectomy. Endocrinological screening (Table I) shows that the tumour was secreting an excess of oestradiol and C-21 steroids. Given the high levels of measured free cortisol in the urine it is remarkable that no Cushingoid features were noted. This may be due to cross-reactivity of glucocorticoid precursors (which such a tumour may produce) with the free cortisol detected by the assay.4 Perhaps the relatively weak glucocorticoid effects of these compounds were not sufficient to have produced a clinical effect at the time of presentation. Depression of serum testosterone by such endocrinologically active tumours is due mainly to gonadotrophic inhibition by high levels of circulating oestradiol, as well as the direct effect of these levels on the Leydig cells.5 It is interesting to note that, although depressed when measured preoperatively, the patient's testosterone level was normal 6 months previously, when he first sought a consultation for his gynaecomastia.
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